↓ Skip to main content

Acetyl-L-Carnitine (Levacecarnine) in the Treatment of Diabetic Neuropathy

Overview of attention for article published in Drugs in R&D, October 2012
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#47 of 376)
  • High Attention Score compared to outputs of the same age (88th percentile)
  • High Attention Score compared to outputs of the same age and source (92nd percentile)

Mentioned by

blogs
1 blog
twitter
1 X user
patent
1 patent
facebook
1 Facebook page
googleplus
1 Google+ user
video
1 YouTube creator

Readers on

mendeley
49 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Acetyl-L-Carnitine (Levacecarnine) in the Treatment of Diabetic Neuropathy
Published in
Drugs in R&D, October 2012
DOI 10.2165/00126839-200203040-00001
Pubmed ID
Authors

Domenico De Grandis, Chiara Minardi

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 49 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Colombia 1 2%
Unknown 48 98%

Demographic breakdown

Readers by professional status Count As %
Student > Master 8 16%
Student > Bachelor 5 10%
Other 4 8%
Researcher 4 8%
Student > Ph. D. Student 3 6%
Other 8 16%
Unknown 17 35%
Readers by discipline Count As %
Medicine and Dentistry 11 22%
Pharmacology, Toxicology and Pharmaceutical Science 5 10%
Agricultural and Biological Sciences 5 10%
Nursing and Health Professions 3 6%
Mathematics 1 2%
Other 3 6%
Unknown 21 43%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 13. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 April 2023.
All research outputs
#2,938,011
of 26,017,215 outputs
Outputs from Drugs in R&D
#47
of 376 outputs
Outputs of similar age
#20,899
of 197,105 outputs
Outputs of similar age from Drugs in R&D
#5
of 71 outputs
Altmetric has tracked 26,017,215 research outputs across all sources so far. Compared to these this one has done well and is in the 88th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 376 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.9. This one has done well, scoring higher than 87% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 197,105 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 88% of its contemporaries.
We're also able to compare this research output to 71 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 92% of its contemporaries.